We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $37M
1-Year Est. Return 63.54%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+63.54%
3 Year Est. Return
+38.32%
5 Year Est. Return
+47.02%
10 Year Est. Return
+2,089.98%
AUM
$988M
AUM Growth
-$950M
Cap. Flow
-$941M
Cap. Flow %
-95.22%
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$23.5M
2
OM icon
Outset Medical
OM
+$11.4M
3
LIVN icon
LivaNova
LIVN
+$8.76M
4
CUTR
Cutera, Inc.
CUTR
+$5.89M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$4.31M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Industrials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
26
CALL
Zimmer Biomet
ZBH
$18.9B
$12.9M 1.31%
+100,000
New +$12.6M
INMD icon
27
PUT
InMode
INMD
$874M
$12.8M 1.29%
400,000
+200,000
+100% +$6.85M
RCM
28
DELISTED
R1 RCM Inc. Common Stock
RCM
$11.5M 1.16%
764,700
+314,700
+70% +$4.31M
RCEL icon
29
Avita Medical
RCEL
$252M
$11.2M 1.13%
798,922
-135,311
-14% -$1.44M
RMD icon
30
PUT
ResMed
RMD
$33B
$10.9M 1.11%
+50,000
New +$10.8M
ISRG icon
31
CALL
Intuitive Surgical
ISRG
$142B
$10.2M 1.03%
40,000
-70,000
-64% -$17.2M
COO icon
32
Cooper Companies
COO
$14.9B
$9.86M 1%
105,672
+44,072
+72% +$3.79M
OLK
33
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$8.88M 0.9%
394,225
-95,902
-20% -$2.09M
GKOS icon
34
CALL
Glaukos
GKOS
$11.2B
$8.26M 0.84%
164,800
-85,200
-34% -$4.14M
AXNX
35
PUT
DELISTED
Axonics, Inc. Common Stock
AXNX
$8.18M 0.83%
+150,000
New +$8.76M
TFX icon
36
PUT
Teleflex
TFX
$5.79B
$7.6M 0.77%
+30,000
New +$7.27M
LUNG icon
37
Pulmonx
LUNG
$98.4M
$7.13M 0.72%
637,513
-378,745
-37% -$3.74M
STAA icon
38
PUT
STAAR Surgical
STAA
$1.24B
$7.03M 0.71%
110,000
-315,000
-74% -$20.6M
A icon
39
PUT
Agilent Technologies
A
$42.2B
$6.92M 0.7%
50,000
+20,000
+67% +$2.92M
RVTY icon
40
CALL
Revvity
RVTY
$13.1B
$6.66M 0.67%
+50,000
New +$6.59M
ALGN icon
41
CALL
Align Technology
ALGN
$12.4B
$6.58M 0.67%
19,700
+7,200
+58% +$2.12M
IART icon
42
PUT
Integra LifeSciences
IART
$1.42B
$6.2M 0.63%
108,000
-93,500
-46% -$5.27M
ALC icon
43
PUT
Alcon
ALC
$35.4B
$6M 0.61%
+85,000
New +$6.05M
SONX
44
DELISTED
Sonendo, Inc.
SONX
$5.96M 0.6%
4,541,805
-374,240
-8% -$849K
EVH icon
45
Evolent Health
EVH
$516M
$5.93M 0.6%
182,877
+66,677
+57% +$2.11M
SDGR icon
46
Schrodinger
SDGR
$1.38B
$5.42M 0.55%
205,684
-54,316
-21% -$1.29M
PHG icon
47
PUT
Philips
PHG
$26.7B
$5.05M 0.51%
321,165
-29,196
-8% -$420K
IMDX
48
Insight Molecular Diagnostics
IMDX
$125M
$5.02M 0.51%
708,308
-194,506
-22% -$1.44M
RGEN icon
49
CALL
Repligen
RGEN
$9.47B
$4.73M 0.48%
+28,100
New +$5.01M
ICUI icon
50
ICU Medical
ICUI
$4.56B
$4.64M 0.47%
28,124
-11,711
-29% -$2.01M

Similar funds

Pura Vida Investments's Q1 2023 Portfolio in Review

As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.

  • Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
  • Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
  • Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
  • Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
  • Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
  • Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.